These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22796753)

  • 1. Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy.
    Selenica ML; Brownlow M; Jimenez JP; Lee DC; Pena G; Dickey CA; Gordon MN; Morgan D
    Neurodegener Dis; 2013; 11(4):165-81. PubMed ID: 22796753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against beta-amyloid reduce Abeta oligomers, glycogen synthase kinase-3beta activation and tau phosphorylation in vivo and in vitro.
    Ma QL; Lim GP; Harris-White ME; Yang F; Ambegaokar SS; Ubeda OJ; Glabe CG; Teter B; Frautschy SA; Cole GM
    J Neurosci Res; 2006 Feb; 83(3):374-84. PubMed ID: 16385556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enduring Elevations of Hippocampal Amyloid Precursor Protein and Iron Are Features of β-Amyloid Toxicity and Are Mediated by Tau.
    Li X; Lei P; Tuo Q; Ayton S; Li QX; Moon S; Volitakis I; Liu R; Masters CL; Finkelstein DI; Bush AI
    Neurotherapeutics; 2015 Oct; 12(4):862-73. PubMed ID: 26260389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
    Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
    Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau.
    Arner A; Rockenstein E; Mante M; Florio J; Masliah D; Salehi B; Adame A; Overk C; Masliah E; Rissman RA
    J Alzheimers Dis; 2018; 61(3):1201-1219. PubMed ID: 29332037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice.
    Lee DC; Rizer J; Selenica ML; Reid P; Kraft C; Johnson A; Blair L; Gordon MN; Dickey CA; Morgan D
    J Neuroinflammation; 2010 Sep; 7():56. PubMed ID: 20846376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy.
    Joly-Amado A; Hunter J; Quadri Z; Zamudio F; Rocha-Rangel PV; Chan D; Kesarwani A; Nash K; Lee DC; Morgan D; Gordon MN; Selenica MB
    Front Immunol; 2020; 11():997. PubMed ID: 32508844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piper sarmentosum Roxb. confers neuroprotection on beta-amyloid (Aβ)-induced microglia-mediated neuroinflammation and attenuates tau hyperphosphorylation in SH-SY5Y cells.
    Yeo ETY; Wong KWL; See ML; Wong KY; Gan SY; Chan EWL
    J Ethnopharmacol; 2018 May; 217():187-194. PubMed ID: 29462698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Interplay of Tau Protein and β-Amyloid: While Tauopathy Spreads More Profoundly Than Amyloidopathy, Both Processes Are Almost Equally Pathogenic.
    Pourhamzeh M; Joghataei MT; Mehrabi S; Ahadi R; Hojjati SMM; Fazli N; Nabavi SM; Pakdaman H; Shahpasand K
    Cell Mol Neurobiol; 2021 Aug; 41(6):1339-1354. PubMed ID: 32696288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased tauopathy drives microglia-mediated clearance of beta-amyloid.
    Chen W; Abud EA; Yeung ST; Lakatos A; Nassi T; Wang J; Blum D; Buée L; Poon WW; Blurton-Jones M
    Acta Neuropathol Commun; 2016 Jun; 4(1):63. PubMed ID: 27339073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurotrophin receptor p75 mediates amyloid β-induced tau pathology.
    Shen LL; Li WW; Xu YL; Gao SH; Xu MY; Bu XL; Liu YH; Wang J; Zhu J; Zeng F; Yao XQ; Gao CY; Xu ZQ; Zhou XF; Wang YJ
    Neurobiol Dis; 2019 Dec; 132():104567. PubMed ID: 31394202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prion protein prevents the inhibition of large-conductance calcium-activated potassium channel by Tau peptide K18 oligomers.
    Kravenska Y; Koprowski P; Nieznanska H; Nieznanski K
    Biochem Biophys Res Commun; 2024 Nov; 734():150793. PubMed ID: 39378784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathogenic role of adenylate kinase-1 in Aβ-mediated tau phosphorylation via AMPK and GSK3β.
    Park H; Kam TI; Kim Y; Choi H; Gwon Y; Kim C; Koh JY; Jung YK
    Hum Mol Genet; 2012 Jun; 21(12):2725-37. PubMed ID: 22419736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid β accelerates phosphorylation of tau and neurofibrillary tangle formation in an amyloid precursor protein and tau double-transgenic mouse model.
    Seino Y; Kawarabayashi T; Wakasaya Y; Watanabe M; Takamura A; Yamamoto-Watanabe Y; Kurata T; Abe K; Ikeda M; Westaway D; Murakami T; Hyslop PS; Matsubara E; Shoji M
    J Neurosci Res; 2010 Dec; 88(16):3547-54. PubMed ID: 20936700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of spleen tyrosine kinase and tau phosphorylated at tyrosine 18 in a mouse model of tauopathy and in the human hippocampus.
    Köhler C; Fuhr V; Dinekov M
    Brain Res; 2017 Dec; 1677():1-13. PubMed ID: 28919467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Near Infrared Light Treatment Reduces Synaptic Levels of Toxic Tau Oligomers in Two Transgenic Mouse Models of Human Tauopathies.
    Comerota MM; Tumurbaatar B; Krishnan B; Kayed R; Taglialatela G
    Mol Neurobiol; 2019 May; 56(5):3341-3355. PubMed ID: 30120733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal changes of CD68 and α7 nicotinic acetylcholine receptor expression in microglia in Alzheimer's disease-like mouse models.
    Matsumura A; Suzuki S; Iwahara N; Hisahara S; Kawamata J; Suzuki H; Yamauchi A; Takata K; Kitamura Y; Shimohama S
    J Alzheimers Dis; 2015; 44(2):409-23. PubMed ID: 25352454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid beta-mediated cell death of cultured hippocampal neurons reveals extensive Tau fragmentation without increased full-length tau phosphorylation.
    Reifert J; Hartung-Cranston D; Feinstein SC
    J Biol Chem; 2011 Jun; 286(23):20797-811. PubMed ID: 21482827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble phospho-tau from Alzheimer's disease hippocampus drives microglial degeneration.
    Sanchez-Mejias E; Navarro V; Jimenez S; Sanchez-Mico M; Sanchez-Varo R; Nuñez-Diaz C; Trujillo-Estrada L; Davila JC; Vizuete M; Gutierrez A; Vitorica J
    Acta Neuropathol; 2016 Dec; 132(6):897-916. PubMed ID: 27743026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrolysin™ efficacy in a transgenic model of tauopathy: role in regulation of mitochondrial structure.
    Rockenstein E; Ubhi K; Trejo M; Mante M; Patrick C; Adame A; Novak P; Jech M; Doppler E; Moessler H; Masliah E
    BMC Neurosci; 2014 Jul; 15():90. PubMed ID: 25047000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.